McKesson CEO – Brian Tyler (Age – 58)

Brian S. Tyler is the CEO of McKesson Corporation (NYSE: MCK), the largest pharmaceutical distributor in North America and one of the biggest companies in the world by revenue. Appointed CEO on April 1, 2019, Tyler succeeded John Hammergren after spending more than 25 years rising through McKesson’s leadership ranks. Under his stewardship, McKesson delivered fiscal year 2025 revenues of $359.1 billion, securing a consistent top-10 position on the Fortune 500. With a market capitalization exceeding $121 billion as of early 2026, McKesson distributes approximately one-third of all pharmaceuticals consumed in North America.

Read on to discover McKesson CEO email address, Brian Tyler net worth in 2026, salary and compensation, career history, education, family, and more.
Brian Tyler McKesson CEO
Brian S. Tyler, Chief Executive Officer of McKesson Corporation • Photo: McKesson

Brian Tyler — Quick Facts

Brian S. Tyler — At a Glance
Full Name Brian Scott Tyler, Ph.D.
Position Chief Executive Officer
Company McKesson Corporation (NYSE: MCK)
Age 58 years (as of 2026)
Education B.A. Economics, UC Santa Cruz; M.A. & Ph.D. Economics, University of Chicago
Net Worth (2026) $50–100 Million (estimated)
Total Compensation ~$20.16 Million (FY2025)
CEO Since April 1, 2019
Previous Role President & Chief Operating Officer, McKesson
Email [email protected]
Fortune 500 Rank Top 10 (by revenue)

McKesson Competitors

McKesson operates in the highly concentrated pharmaceutical distribution industry. Together with its two main rivals, McKesson controls over 90% of the U.S. pharmaceutical distribution market. Key competitors include:

  • Cencora (formerly AmerisourceBergen) — McKesson’s most direct rival with $294B+ in annual revenue
  • Cardinal Health — The third member of the pharmaceutical distribution oligopoly
  • Owens & Minor — Competes in medical-surgical distribution
  • Henry Schein — Healthcare products distribution
  • Medline Industries — Major player in medical-surgical supplies
  • CVS Health — Retail pharmacy and healthcare services
  • Walgreens Boots Alliance — Pharmacy-led healthcare company

Brian Tyler Net Worth 2026 — McKesson CEO Salary

As of 2026, Brian Tyler’s net worth is estimated at approximately $50-100 million, based on his cumulative compensation over more than seven years as CEO, SEC-disclosed stock holdings, and long-term equity awards. According to insider trading filings, Tyler directly owns approximately 4,227 shares of McKesson (MCK) stock worth over $3.59 million, though this represents only his direct holdings and does not include previously vested and sold equity awards.

Over the past 18 months, Tyler has made 11 insider transactions in McKesson stock, with a net sale of 109,705 shares — a common practice among Fortune 500 executives for diversification and tax planning.

McKesson CEO Compensation Breakdown (FY2025)

Component Amount (USD) Share
Base Salary $1,541,667 7.6%
Annual Bonus $3,669,167 18.2%
Stock Awards $14,500,512 71.9%
Other Compensation $450,368 2.2%
TOTAL $20,161,714 100%
Key Insight: Over 92.4% of Brian Tyler’s compensation is performance-based (bonus + equity), with only 7.6% from base salary. McKesson’s CEO pay ratio is 293:1 relative to the median employee. His FY2024 total compensation was $18.99 million, meaning his FY2025 package rose approximately 6% year-over-year.

McKesson Net Worth 2026 — Is McKesson Profitable?

Yes, McKesson is a highly profitable company and one of the largest in the world by revenue. Under CEO Brian Tyler, McKesson has delivered consistent growth across all key financial metrics.

McKesson Financial Summary (FY2025 vs FY2024)

Metric FY2025 FY2024 YoY Change
Revenue $359.1B $309.0B ▲ 16.2%
Net Income $3.48B $3.00B ▲ 16.0%
Adjusted EPS $33.05 $27.44 ▲ 20.4%
Cash Flow from Operations $6.1B
Free Cash Flow $5.2B
Market Capitalization ~$121B ~$72B ▲ 68%
Employees ~51,000
NYSE Ticker MCK
Growth Under Tyler: Since Brian Tyler became CEO in April 2019, McKesson’s market capitalization has soared from roughly $25 billion to over $121 billion — nearly a 5x increase. Revenue grew from approximately $214 billion (FY2019) to $359.1 billion (FY2025), and the stock price has risen more than 59% in the past year alone.

McKesson CEO Email Address | Brian Tyler Contact

Below are the official contact details for McKesson CEO Brian Tyler:

Contact Information
Email Address [email protected]
Email Format [email protected]
LinkedIn Brian Tyler — CEO at McKesson
Corporate HQ 6555 State Hwy 161, Irving, TX 75039
Phone (972) 446-4800
Investor Relations [email protected]

Career & Education — Company, University, & College

Brian Tyler’s career has been defined by his deep commitment to McKesson, where he has spent more than 25 years. Before joining the company, Tyler applied his economics expertise in healthcare consulting. Below is his complete career timeline:

Brian Tyler Career Timeline

Period Role Company
1989 B.A. Economics (High Honors) UC Santa Cruz
1989-1994 M.A. & Ph.D. in Economics (NSF Grant) University of Chicago
~1994-1997 Senior Associate, Health Care Consulting Integral, Inc. (Cambridge, MA)
1997 VP, Strategy & Business Development McKesson Distribution Solutions
2012-2015 EVP, Corporate Strategy & Business Development McKesson Corporation
2015-2016 President, North American Pharmaceutical Distribution McKesson Corporation
2016-2018 President & COO, McKesson Europe; Chairman, McKesson Europe AG McKesson Europe
Aug 2018-Mar 2019 President & Chief Operating Officer McKesson Corporation
Apr 2019-Present Chief Executive Officer McKesson Corporation

Brian Tyler joined McKesson in 1997 as vice president of strategy and business development for McKesson Distribution Solutions. Over the following two decades, he held leadership positions spanning virtually every major division of the company, including McKesson Europe, North American Pharmaceutical Distribution, Corporate Strategy, U.S. Pharmaceutical, Medical-Surgical Solutions, and McKesson Specialty Care Solutions.

His international experience was pivotal — as President and COO of McKesson Europe and Chairman of the Management Board of McKesson Europe AG from 2016 to 2018, Tyler gained a deep understanding of global pharmaceutical distribution markets. He was then promoted to President and Chief Operating Officer of the entire corporation in August 2018 before assuming the CEO role on April 1, 2019.

Before McKesson, Tyler spent approximately three years at Integral, Inc. in Cambridge, Massachusetts, as a senior associate in healthcare consulting, where he applied his doctoral economics training to healthcare industry challenges.

Education

University Degree / Program Website
University of California, Santa Cruz B.A. in Economics (High Honors), 1989 ucsc.edu
University of Chicago, Department of Economics M.A. & Ph.D. in Economics (NSF Fellow), 1994 uchicago.edu

Tyler earned his undergraduate degree in economics with high honors from the University of California, Santa Cruz in 1989. He then pursued graduate studies at the University of Chicago‘s Department of Economics — one of the most prestigious economics programs in the world — where he completed both his M.A. and Ph.D. His doctoral specializations included industrial organization, labor economics, and public finance/project evaluation. He studied under a grant from the National Science Foundation (NSF).

University of Chicago campus where Brian Tyler earned his Ph.D. in Economics
University campus — Brian Tyler earned his M.A. and Ph.D. in Economics from the prestigious University of Chicago. Photo: Unsplash

Brian Tyler Wiki — Age, Family, & More

McKesson CEO Brian Tyler (age 58) is based in the Irving, Texas area near McKesson’s corporate headquarters. Tyler keeps his personal and family life relatively private, though he is known to be a parent. He maintains a low public profile outside of his corporate responsibilities, focusing his energy on McKesson’s mission of improving healthcare delivery.

Board Memberships & Community Involvement

  • Republic Services, Inc. — Board of Directors member since March 2021
  • International Federation of Pharmaceutical Wholesalers (IFPW) — Board of Directors member
  • American Cancer Society — Chair, North Texas chapter of CEOs Against Cancer
  • Business Roundtable — Active member
  • SMU Commencement Speaker — Featured keynote speaker at Southern Methodist University’s commencement

Tyler was honored by the American Cancer Society with its St. George National Award, recognizing his significant contributions to cancer research and care. He is a passionate advocate for improving healthcare access and has spoken publicly about McKesson’s role in critical national health initiatives, including COVID-19 vaccine distribution.

About McKesson Corporation

McKesson Corporation is an American healthcare services and pharmaceutical distribution company headquartered in Irving, Texas. Founded in 1833 by John McKesson and Charles Olcott in New York City, it is one of the oldest continuously operating companies in America at nearly 200 years old. McKesson distributes approximately one-third of all pharmaceuticals consumed in North America.

Segment Focus Description
U.S. Pharmaceutical Drug distribution Distributes branded, generic, and specialty drugs to pharmacies, hospitals, and health systems
Prescription Technology Solutions Technology Pharmacy automation, patient access, and adherence technology
Medical-Surgical Solutions Med-surg supplies Distributes medical-surgical supplies to physician offices, surgery centers, and long-term care facilities
International Global operations Pharmaceutical distribution in Canada and other international markets
Fun Fact: McKesson was founded in 1833, making it nearly 200 years old — one of the oldest companies in America. The original founders, John McKesson and Charles Olcott, started by importing and selling therapeutic drugs from a shop in New York City, stocking medicine chests aboard trade ships. Today, McKesson’s FY2025 revenue of $359.1 billion exceeds the GDP of most countries.

Frequently Asked Questions (FAQ)

Who is the current CEO of McKesson?

Brian S. Tyler has been CEO of McKesson Corporation since April 1, 2019, succeeding John Hammergren. Tyler holds a Ph.D. in Economics from the University of Chicago and spent more than 25 years at McKesson before becoming CEO.

What is Brian Tyler’s net worth in 2026?

Brian Tyler’s net worth is estimated at $50-100 million as of 2026, based on cumulative compensation, stock holdings, and equity awards. His direct McKesson stock holdings are worth approximately $3.59 million.

What is McKesson CEO’s salary?

Brian Tyler’s total compensation for fiscal year 2025 was approximately $20.16 million, including a $1.54 million base salary, $3.67 million annual bonus, $14.5 million in stock awards, and $450,000 in other compensation. Over 92% of his pay is performance-based.

What is McKesson CEO’s email address?

McKesson CEO Brian Tyler’s email address is [email protected]. McKesson uses the [email protected] format. The corporate headquarters is at 6555 State Hwy 161, Irving, TX 75039, phone (972) 446-4800.

How big is McKesson?

McKesson is one of the largest companies in the world by revenue ($359.1 billion in FY2025), consistently ranking in the Fortune 500 top 10. It has a market capitalization exceeding $121 billion and distributes approximately one-third of all pharmaceuticals in North America.

What is Brian Tyler’s educational background?

Brian Tyler earned a B.A. in Economics with high honors from the University of California, Santa Cruz in 1989, and both an M.A. and Ph.D. in Economics from the University of Chicago in 1994. He studied under a National Science Foundation grant, specializing in industrial organization, labor economics, and public finance.

Article last updated:January 2026March 4, 2026

Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, McKesson proxy statements, and reputable news outlets. Net worth figures are estimates based on disclosed stock holdings and may not reflect the complete financial picture. This content is provided for informational purposes only and does not constitute financial or investment advice.